AstraZeneca and insitro Partner on AI-Driven Drug Discovery
AstraZeneca has collaborated with insitro to use advanced AI systems to develop transformative therapeutics for difficult to treat cardiometabolic diseases.
Drug Discovery For MASH | 16/10/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy